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Abstract
Background: Hypoxia resulting from adipocyte expansion is considered the basis of the inflammatory milieu
observed in Metabolic Syndrome. Nicotinic acid can act on adipocytes interfering on the inflammatory response.
In this study, we investigated the role of HIF-1 α (hypoxia-inducible factor -1 alpha) in the inflammatory process
induced by hypoxia. The effect of nicotinic acid on the PPARs (peroxisome proliferator-activated receptors)
expression during the inflammatory response was assessed over its action under HIF-1 α in 3T3-L1 adipocytes
submitted to hypoxia.
Methods: 3T3-L1 adipocytes were pre-treated with nicotinic acid and incubated under hypoxic conditions. The
level of adipokines and HIF-1 α were quantified using immunoassays. Adipokine expression was measured using
real-time PCR, whereas PPARs and HIF-1 α expression were analyzed by western blot. The statistical significance
of the differences between variables studied was determined by analysis of variance (ANOVA) complemented by
Bonferroni’s test.
Results: The results demonstrated an increase in leptin and PAI-1 (plasminogen activator inhibitor-1) expression,
while adiponectin production decreased under hypoxia. In parallel, induction with hypoxia enhanced HIF-1 α
expression, despite causing reduced expression of PPAR α and PPAR γ. However, nicotinic acid reversed adipokine
modulation under hypoxic conditions, leading to decreased HIF-1 α expression and increased PPARs expression.
Conclusions: Our findings suggest that nicotinic acid blunt the inflammatory response resulting from hypoxia by
the reduction of HIF-1 α expression and concomitant increase of PPARs α and γ expression in 3T3-L1 adipocytes.
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Background
Obesity, a world epidemic disease, is characterized by
the expansion of adipose tissue mass, resulting in a
state of chronic low-grade inflammation, which con-
tributes to the development of cardiovascular diseases
[1]. Oxygen deprivation, a result of such tissue expan-
sion, is the component leading to an increase of inflam-
matory proteins in the obesity pathogenesis [2]. Low
oxygen tension induces adaptive response in cells to
conserve oxygen for vital metabolic functions, these
changes occur through the activation of a specific tran-
scription factor called hypoxia-inducible factor 1 (HIF-1).
HIF-1 is a heterodimer composed of HIF-1 α, which is
considered the molecular oxygen sensor, and HIF-1 β,
which is associated with the receptor nuclear translocator
[3]. Wang et al. reported that low oxygen tension in
human adipocytes induced a marked increase in HIF-1 α
expression with a concomitant increase in the secretion
and expression of several adipokines, including leptin and
plasminogen activator inhibitor-1 (PAI-1), whereas adi-
ponectin was inhibited during such oxygen deprivation
[4]. Indeed, subsequent studies demonstrated that, in
vitro, hypoxia downregulates the expression of peroxi-
some proliferator-activated receptors ɑ and γ (PPAR α
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and PPAR γ) [5, 6]. These findings may provide evi-
dence of an adaptive response to inflammatory pro-
cesses during a hypoxic state.
Nicotinic acid targets adipocytes through the activa-
tion of a G-protein-coupled receptor (GPR-109 A) which
is highly expressed in adipose tissue [7]. The activation
of GPR-109 A results in an increased adiponectin levels
and an attenuation in leptin and PAI-1 secretion from
adipocytes [8]. Digby et al. found that nicotinic acid sup-
pressed pro-inflammatory proteins and upregulated the
production of atheroprotective adiponectin in 3T3-L1
adipocytes [9]. However, the mechanism by which nico-
tinic acid affects the expression of PPAR γ and PPAR ɑ
is not fully understood. Yang et al. also reported a sig-
nificant increase of PPAR γ mRNA expression in hyper-
cholesterolemic rabbit adipocytes treated with the drug,
suggesting that this receptor can also stimulate the tran-
scription of genes involving in the regulation of several
inflammatory adipokines [10].
In the present study, we investigated the link between
inflammatory response induced by oxygen deprivation and
the role of PPAR γ and PPAR α under hypoxic conditions.
We speculate whether the potential benefits, observed
from nicotinic acid in mitigation of the inflammatory re-
sponse associated with hypoxia, are mediated by HIF-1 α
under PPAR α and PPAR γ activation.
Methods
Cell culture
Murine fibroblasts of the immortalized 3T3-L1 cell line
in the 7th passage were obtained from the American
Type Culture Collection and were grown in DMEM-HG
(Dulbecco’s modified Eagle’s medium high glucose, Gibco,
NY, USA) containing 10 % (v/v) fetal bovine serum (FBS,
Gibco, NY,USA). Confluent cells were induced to differen-
tiate into adipocytes, according to a previously established
protocol [11, 12].
Cell treatment
On the 10th day following the beginning of differenti-
ation, the adipocytes were pre-treated with nicotinic
acid (10 μmol/L) (Sigma Aldrich, St. Louis, MO, USA)
or the vehicle control (non-supplemented DMEM HG
medium) for 24 h at 37 ° C in an incubator containing
5 % CO2 and ideal humidity conditions. After the nico-
tinic acid treatment, the cells were exposed to hypoxia
(1 % O2, 94 % N2 and 5 % CO2), sealed and placed at
37 ° C for different periods of time (4, 8 and 12 h). Ser-
ial dilutions of nicotinic acid had been previously tested
to obtain a working concentration of 10 μmol/L (Fig. 1).
Oxygen saturation was performed in all groups using a
blood gas analyzer (ABL5 - Radiometer Copenhagen,
Holliston, MA, USA) from laboratory of Hospital do
Rim (data not shown).
Differentiation of fibroblasts into adipocytes by oil
red staining
The differentiation of 3T3-L1fibroblast into adipocytes
was evaluated every 24 h from the 10th day following the
beginning of differentiation by observing the morpho-
logic appearance of the cells with a light microscope. On
the 10th day, the formation of lipid droplets, a morpho-
logic appearance characteristic of adipocytes, was con-
firmed by oil red (Sigma Aldrich, St. Louis, MO, USA)
staining. (data not shown).
Initially, 60 mg of oil red stain were dissolved in
20 mL of isopropanol. After 300 μL of this solution
were diluted in water in 6:4 proportions. Culture
medium was aspirated and the wells were washed twice
with phosphate-buffered saline (PBS). Next, 4 % para-
formaldehyde (diluted in PBS) was added in a volume
sufficient to cover the cells. After 30 min at room
temperature, the medium was aspirated and the wells
were washed 3 times with PBS. The cells were then in-
cubated in oil red solution (300 μL) for 2 h, at 37 ° C.
Afterward, the medium was aspirated, and the plates
were washed thrice with distilled water and placed into
the incubator, at 37 ° C to dry. After this step, the cells
were examined with optic microscope and photographs
were taken.
Determination of cell viability
We could observe by trypan blue (Sigma Aldrich, St.
Louis, MO, USA) exclusion that from the 4th to the 10th
day, at the beginning of differentiation, cell viability was
about 95 % (data not shown). The cells were trypsinized
Fig. 1 Dose effects of nicotinic acid on adiponectin secretion. Serial
dilutions of nicotinic acid on adiponectin secretion in 3T3-L1 adipocytes;
*10 μM, 25 μM, 50 μM groups versus Control group, p < 0.05. The
statistical significance of the differences between variables studied
was determined by analysis of variance (ANOVA) - n = 6
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and suspended in 10 mL of PBS. A 25 μL aliquot of this
cell suspension was mixed with 75 μL of trypan blue
stain. From this mixture, 10 μL were placed in a Neu-
bauer chamber to count viable nucleus cells stained in
red.
Measurement of HIF-1 α and adipokines by ELISA
Total HIF-1 α in the cell lysates was quantified using an
immunoassay kit (ELISA) (R&D Systems, Minneapolis,
MN, USA), according to the manufacturer’s protocol.
The cells were lysed as previously described by Wang
et al. [4]. The secretion of the adipokines in 3T3-L1
adipocytes was determined by measuring the leptin,
PAI-1 and adiponectin concentrations in the cell cul-
ture medium using a commercial ELISA kit (Linco Re-
search – Millipore, St. Charles, MO, USA; Wuhan
EIAAB Science CO., LTD, Wuhan, China and R&D
System, Minneapolis, MN, USA, respectively), accord-
ing to the manufacturer’s protocol.
mRNA extraction and cDNA synthesis
Total mRNA from mature adipocytes was extracted with
QuantiTeck kit (Qiagen, Hilden, NRW, German) accord-
ing to the manufacture’s protocol. After, cDNA was pre-
pared using 1 μg of total RNA by the appropriate kit
(RevertAid H Minus First Strand cDNA Synthesis Kit,
Thermo Scientific, Pittsburgh, PA, EUA).
Analysis of adipokines expression by real time PCR
An aliquot of cDNA was mixed with the specific primers
for the genes of interest, along with deoxynucleotides,
Taq polymerase and the fluorescent stain SybrGreen
(Quantitect kit, Qiagen, Hilden, NRW, German). Primers
for the genes of interest were designed using the Primer
Express® program (Applied Biosystems, Gibco, NY, USA)
and were based on the gene sequences obtained from
GenBank. The primer sequences are described in the
Table 1.
Reactions utilizing the specific primers were systemat-
ically performed. The specificity of the product was con-
firmed by melting point curve analysis, as well as by
conventional agarose gel electrophoresis. The products
were quantified and compared to controls based on the
analysis of the number cycles necessary to obtain a given
fluorescence value in the log-linear phase of the reac-
tion. Reactions utilizing the primer for the housekeeping
gene HPRT (hypoxanthine phosphoribosyl transferase)
were systematically performed, and all values obtained
for the genes of interest were normalized with HPRT
expression.
Analysis of HIF-1 ɑ, PPAR α and PPAR γ by western blot
Total protein was extracted from 3T3-L1 adipocytes.
Next, the samples were concentrated using Centrifugal
Filter Devices (Milipore, St. Charles, MO, USA) and a
Speed Vac Concentrator (SPD111V, Thermo Scientific,
Pittsburgh PA, USA). Total protein was quantified using
the BCA Protein Assay reagent (Thermo Scientific,
Pittsburgh PA, USA), and 20 μg protein was separated
by SDS-PAGE and transferred onto nitrocellulose mem-
branes. These membranes were blocked and probed with
mouse monoclonal anti-HIF-1 ɑ (Milipore, St. Charles,
MO, USA) or rabbit polyclonal anti-PPARγ (Milipore,
St. Charles, MO, USA) or mouse monoclonal anti-PPAR
ɑ (Milipore, St. Charles, MO, USA) or mouse anti-actin
(Sigma Aldrich, St. Louis, MO, USA) as the primary anti-
body. The membranes were then submitted to peroxidase-
conjugated goat anti-mouse IgG (Milipore, St. Charles,
MO, USA) or peroxidase-conjugated goat ant-rabbit IgG
(Milipore, St. Charles, MO, USA).
The specific proteins were observed following incubation
with the chemiluminescent HRP substrate (Immobilon
Western, Millipore, St. Charles, MO, USA). The densito-
metric analyses of the proteins of interest were performed,
using UVI band software (Univitec – Cambridge, England).
Statiscal analysis
Statistical analysis was performed using the SPSS 20.0
software. The results for each individual group were
expressed as mean ± standard deviation. The statistical
significance of the differences between variables studied
was determined by analysis of variance (ANOVA) com-
plemented by Bonferroni’s test. The level of statistical
significance was 0.05 for all tests.
Results
Total HIF- 1 α intracellular concentration and expression
and PPAR α and PPAR γ expression
We observed a gradual increase in HIF-1 ɑ intracellular
concentration during the different periods of hypoxia
compared to the baseline conditions (Fig. 2). However,
we verified that the pre-treatment with nicotinic acid de-
creased the total HIF-1 α intracellular concentration in
adipocytes incubated under hypoxic conditions for dif-
ferent periods of time compared to cells cultured only
under the respective periods of oxygen deprivation. The
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treatment with nicotinic acid didn’t exert effects on HIF-
1 α compared to baseline conditions (Fig. 2). Analysis of
the western blot images demonstrated an enhanced HIF-
1 α expression and showed a decrease in PPAR α and
PPAR γ expression in adipocytes exposed to different pe-
riods of hypoxia compared to the baseline conditions in
3T3-L1 adipocytes (Fig. 3). Moreover, we observed that
adipocytes pre-treated with the drug had also decreased
HIF-1 α expression and enhanced PPAR α and PPAR γ
expression during the different periods of hypoxia com-
pared to the cells submitted to only oxygen deprivation
(Fig. 3).
Leptin and PAI-1 secretion and expression
Hypoxia activated the secretion of leptin in the differ-
ent periods compared to the control group (Fig. 4a).
We also verified an increase in PAI-1 secretion in adi-
pocytes submitted to the different periods of hypoxia
compared to the control group (Fig. 4b). The pre-
treatment with nicotinic acid suppressed leptin secre-
tion in adipocytes exposed to the different periods of
oxygen deprivation compared to cells cultured only
under the respective periods of hypoxia (Fig. 4a). Fur-
thermore, we observed a decrease in PAI-1 secretion in
adipocytes pre-treated with nicotinic acid and submit-
ted to hypoxia compared to the respective periods of
oxygen deprivation (Fig. 4b). The treatment with nico-
tinic acid decreased the leptin secretion compared to
control group (Fig. 4a), but didn’t exert effects on PAI-
1 secretion (Fig. 4b). The analysis of real time PCR
demonstrated an increase of leptin and PAI-1 expres-
sion in adipocytes submitted to hypoxia compared to
Fig. 2 HIF-1 ɑ intracellular concentration in adipocytes pre-treated
with nicotinic acid and submitted to hypoxia. HIF-1α intracellular
concentration in 3T3-L1 adipocytes; •H4 h, H8 h, H12 h groups versus
Control group; * DH4 h versus H 4 h; ** DH 8 h versus H8 h; *** DH
12 h versus H12 h, p < 0.05. The statistical significance of the differences
between variables studied was determined by analysis of variance
(ANOVA) - n = 10; NA: Nicotinic acid, H: hypoxia; DH: Drug + Hypoxia
Fig. 3 Expression of HIF-1 ɑ, PPAR ɑ and PPAR γ in adipocytes
pre-treated with nicotinic acid and submitted to hypoxia. a Expression
of HIF-1 α, PPAR α and PPAR γ in 3T3-L1 adipocytes through
Western blot. b Densitometric analysis of HIF-1 α by Western blot.
c Densitometric analysis of PPAR α expression by Western Blot. d
Densitometric analysis of PPAR γ by Western blot. †NA versus Control
group; •H 4 h, H 8 h, H 12 h groups versus Control group; *DH 4 h
versus H 4 h; **DH 8 h versus H 8 h; ***DH 12 h versus H 12 h, p <
0.05. The statistical significance of the differences between variables
studied was determined by analysis of variance (ANOVA) - n = 6;
NA: Nicotinic acid; H: Hypoxia; DH: Drug + Hypoxia
Nakamichi et al. Lipids in Health and Disease  (2016) 15:91 Page 4 of 8
control group (Table 2) and a suppression of these adi-
pokines expression in adipocytes pre-treated with nico-
tinic acid and exposed to hypoxia compared to cells
only submitted to the respective periods of oxygen
deprivation. Moreover, the treatment with nicotinic
acid decreased leptin and PAI-1 expression (Table 2).
Adiponectin secretion and expression
Hypoxia decreased the expression (Table 2) and secretion
of adiponectin compared to control group (Fig. 5). Pre-
treatment with nicotinic acid increased the expression
(Table 2) and secretion of adiponectin in the cells submit-
ted to the different periods of oxygen deprivation com-
pared to the adipocytes only exposed to the respective
periods of hypoxia (Fig. 5). The treatment with nicotinic
acid enhanced the expression (Table 2) and the secretion
of adiponectin compared to control group (Fig. 5).
Correlation between HIF- 1α and the leptin, PAI-1and
adiponectin secretion
We observed a correlation between HIF- 1alpha and lep-
tin (R2 = 0.95) (Fig. 6a), PAI-1(R2 = 0.79) (Fig. 6b) and
adiponectin secretion (R2 = 0.68) (Fig. 6c).
Discussion
There is increasing evidence that low oxygen tension
impairs adipocyte function, modulates the expression of
adipokines and contributes to metabolic disorders
through the induction of adaptive responses. In the
present study, we found that hypoxia mediates an in-
crease in inflammatory proteins, such as leptin and
Fig. 4 Secretion of leptin and PAI-1 in adipocytes pre-treated with nicotinic acid and submitted to hypoxia. a Secretion of leptin in 3T3-L1
adipocytes. b Secretion of PAI-1 in 3T3-L1 adipocytes; †NA versus Control group; •H 4 h, H 8 h, H 12 h groups versus Control group; *DH 4 h
versus H 4 h; **DH 8 h versus H 8 h; ***DH 12 h versus H 12 h, p < 0.05. The statistical significance of the differences between variables studied was
determined by analysis of variance (ANOVA) - n = 10; NA: Nicotinic acid; H: Hypoxia; DH: Drug + Hypoxia
Table 2 Expression of leptin, PAI-1 and adiponectin in 3T3-L1 adipocytes
Relative mRNA expression Control NA H 4 h H 8 h H 12 h DH 4 h DH 8 h DH 12 h
Leptin 0.2 ± 0.3 0.4 ± 0.007a 136.4 ± 17.0b 320.7 ± 72.3b 571.7 ± 53.6b 5.06 ± 3.1c 26.8 ± 9.4d 74.7 ± 14.1e
PAI-1 1.4 ± 0.4 0.04 ± 0.04a 7.3 ± 2.7b 16.0 ± 2.7b 30.6 ± 7.4b 0.2 ± 0.3c 0.6 ± 0.4d 8.0 ± 3.5e
Adiponectin 255.1 ± 130.7 1195.7 ± 418.7a 2.9 ± 2.0b 0.6 ± 0.2b 0.08 ± 0.02b 278.7 ± 146.7c 214.3 ± 62.7d 22.2 ± 9.8e
Expression of adipokines in adipocytes: aNA versus Control group; bH 4 h, H 8 h, H 12 h groups versus Control group; cDH 4 h versus H 4 h; dDH 8 h versus H 8 h;
eDH 12 h versus H 12 h, p < 0.05. The statistical significance of the differences between variables studied was determined by analysis of variance (ANOVA) - n=10;
NA: Nicotinic acid; H: Hypoxia; DH: Drug + Hypoxia
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PAI-1, while resulting in a decrease in adiponectin ex-
pression and secretion. In parallel, we demonstrated an
enhancer of HIF-1 ɑ in hypoxic 3T3-L1 adipocytes. In
fact, Hosogai et al. showed that HIF-1 α downregulated
the expression of adiponectin mRNA and amplified the
synthesis of PAI-1 in the adipose tissue of obese mice [2].
Halberg et al. reported that transgenic expression of a
constitutively active form of this transcription factor in-
duced glucose tolerance in rats [13]. These results corrob-
orate the hypothesis that HIF-1 α plays an important role
in the transmission of the hypoxic response in adipose tis-
sue. HIF-1 α is considered to be the major molecular oxy-
gen sensor that regulates the expression of a large group
of genes related to several physiological processes such as
erythropoiesis, angiogenesis and glycolysis [14].
The precise role of HIF-1 α in modulating adipokine
production remains poorly characterized, but recent
studies have indicated that PPARs are involved in this
mechanism. Our findings demonstrated a reduction in
PPAR α and PPAR γ expression with a concomitant
increase in HIF-1 ɑ expression; at the same time, we ob-
served changes in the synthesis and release of adipokines
under conditions of oxygen deprivation. Pino et al. con-
firmed the role of PPAR γ in regulating the response of
white adipose tissue to hypoxia [5]. On the basis of our
findings, it is possible that HIF-1 α modulates leptin,
PAI-1 and adiponectin secretion and expression through
the PPARs pathway. Although this mechanism is not
fully understood, a number of studies have emphasized
such a possibility. Narravula and Colgan associated the
downregulation of PPAR α with HIF-1 α induction in
intestinal epithelial cells. In parallel, they identified a
binding site for HIF-1 α on the antisense strand of the
PPAR α gene, resulting in an increase in inflammation-
related gene products [6]. Additionally, Nicolla et al.
observed that HIF-1 α requires cofactors, such as PPAR γ,
to facilitate the expression of hypoxia-associated genes by
interfacing with components bound to the regulatory
elements in the corresponding promoter regions under low
oxygen tension in rats [15]. The expansion of adipose tissue
results in the infiltration of macrophages and the produc-
tion of inflammatory proteins, which reduces PPAR γ activ-
ity on select target genes and results in an increase in HIF-
Fig. 5 Secretion of adiponectin in adipocytes pre-treated with
nicotinic acid and submitted to hypoxia. Secretion of adiponectin
in 3T3-L1 adipocytes; † NA versus Control group; • H4 h, H8 h,
H12 h groups versus Control group; * DH 4 h versus H 4 h; ** DH
8 h versus H 8 h; *** DH 12 h versus H 12 h, p < 0.05. The statistical
significance of the differences between variables studied was
determined by analysis of variance (ANOVA) - n = 10; NA: Nicotinic
acid; H: Hypoxia; DH: Drug + Hypoxia
Fig. 6 Correlation between HIF-1 α concentration and adipokines
secretion. a Correlation between HIF-1 α and leptin, R2 = 0.94, p =
0.01. b Correlation between HIF-1 α and PAI-1, R2 = 0.80, p = 0.01. c
Correlation between HIF-1 α and adiponectin, R2 = 0.70, p = 0.01.
The statistical significance between variables studied was determined
by Pearson Correlation- n = 10
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1 α activity. This increased activity leads to the suppression
of beneficial adipokine expression, such as adiponectin, and
the increased expression of leptin and PAI-1 [16].
We also studied the effect of nicotinic acid on the at-
tenuation of the inflammatory response associated with
hypoxia. In this regard, we showed a modulation of adi-
pokines in hypoxic adipocytes exposed to nicotinic acid.
Recent studies have demonstrated the action of nico-
tinic acid on the attenuation of inflammatory process
through the activation of its specific receptor GPR-109
A [7], highly expressed in adipose tissue [9, 10]. Indeed,
Plaisance et al. showed the role of GPR-109 A in the
regulation of adiponectin production, demonstrating an
increase in the adiponectin secretion through the acti-
vation of the receptor in 3T3-L1 adipocytes [17].
As previously described, the importance of HIF- 1 α
in the adaptation of cells to low oxygen tension and its
effects on the expression of genes involving in angio-
genesis, glucose metabolism and erythropoiesis make
this transcription factor an attractive target [3]. In fact,
several studies have demonstrated that HIF-1 α is im-
plicated in metabolic disorders in other tissues as liver,
lung, breast [18, 19]. Additionally, natural antagonists
or antisense strategies have been applied in mouse
models, and therapeutic strategies have focused on de-
veloping new small-molecule HIF-1 ɑ inhibitors [20].
Recently, Jiang et al. demonstrated that acriflavine (ACF),
a HIF-1 inhibitor, increased the expression of adiponectin,
suggesting its potential as a therapeutic treatment for
obesity and type 2 diabetes [21]. Moreover, Boovanahalli
et al. suggested that isonicotinic and nicotinic acid deri-
vates may inhibit HIF-1 α activity [22].
Less is known about whether HIF-1 α can be blocked
by its inhibitors or whether nicotinic acid can reverse
the inflammation mediated by this transcription factor.
On the basis of our findings, nicotinic acid acts by redu-
cing the expression of inflammatory adipokines and in-
creasing the expression of adiponectin, which is related
to the enhancement of PPAR γ and PPAR α expression
observed in 3T3-L1 adipocytes. Therefore, we speculate
that nicotinic acid inhibits HIF-1 α through the PPARs
pathway, thus resulting in the reversal of the inflamma-
tory response mediated by hypoxia. Increasing amounts
of evidence suggest that PPAR γ also has high affinity
for certain drugs, such as nicotinic acid [23]. It has been
shown that nicotinic acid induces PPAR γ expression
and the transcriptional activation in macrophages via
GPR-109 A mediated induction of prostaglandin syn-
thesis pathways [24]. Rubic et al. suggested that nico-
tinic acid acts on the translocation and transcription of
PPAR γ, which indirectly stimulates prostaglandin D2
and consequently prostaglandin J2, an endogenous lig-
and of PPAR γ, thereby increasing adiponectin expres-
sion [25]. Indeed, this mechanism was also observed to
be the responsible mechanism, since leptin production
decreased after treatment with acipimox, a nicotinic
acid analogue [26].
Conclusion
In conclusion, the present study demonstrated that
hypoxia induces adipokine modulation, while increasing
HIF-1 ɑ secretion and expression. This was in parallel
to its suppression of PPAR ɑ and PPAR γ under hyp-
oxic conditions, suggesting a possible link between the
two pathways. Our findings also propose, that nicotinic
acid is related to the amelioration of hypoxic effects in
3T3-L1 adipocytes. Whether the results obtained can
be translated to the clinical setting is still a matter of
debate and should be the objective of future studies.
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